Carbone DP - Search Results

1

Nuclear survivin predicts recurrence and poor survival in patients with resected nonsmall cell lung carcinoma.

Shinohara ET, Gonzalez A, Massion PP, Chen H, Li M, Freyer AS, Olson SJ, Andersen JJ, Shyr Y, Carbone DP, Johnson DH, Hallahan DE, Lu B. Shinohara ET, et al. Among authors: carbone dp. Cancer. 2005 Apr 15;103(8):1685-92. doi: 10.1002/cncr.20951. Cancer. 2005. PMID: 15742356 Free article.

2

Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.

Winter SF, Minna JD, Johnson BE, Takahashi T, Gazdar AF, Carbone DP. Winter SF, et al. Among authors: carbone dp. Cancer Res. 1992 Aug 1;52(15):4168-74. Cancer Res. 1992. PMID: 1322237

3

Antibodies against autologous tumor cell proteins in patients with small-cell lung cancer: association with improved survival.

Winter SF, Sekido Y, Minna JD, McIntire D, Johnson BE, Gazdar AF, Carbone DP. Winter SF, et al. Among authors: carbone dp. J Natl Cancer Inst. 1993 Dec 15;85(24):2012-8. doi: 10.1093/jnci/85.24.2012. J Natl Cancer Inst. 1993. PMID: 8246287

4

Gene therapy for lung cancer.

Lee CT, Chen HL, Carbone DP. Lee CT, et al. Among authors: carbone dp. Ann Oncol. 1995;6 Suppl 3:S61-3. doi: 10.1093/annonc/6.suppl_3.s61. Ann Oncol. 1995. PMID: 8616119 Free article. Review.

5

Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines.

Lee CT, Wu S, Gabrilovich D, Chen H, Nadaf-Rahrov S, Ciernik IF, Carbone DP. Lee CT, et al. Among authors: carbone dp. Cancer Res. 1996 Jul 1;56(13):3038-41. Cancer Res. 1996. PMID: 8674059

6

Structural and functional analysis of beta2 microglobulin abnormalities in human lung and breast cancer.

Chen HL, Gabrilovich D, Virmani A, Ratnani I, Girgis KR, Nadaf-Rahrov S, Fernandez-Viña M, Carbone DP. Chen HL, et al. Among authors: carbone dp. Int J Cancer. 1996 Sep 17;67(6):756-63. doi: 10.1002/(SICI)1097-0215(19960917)67:6<756::AID-IJC2>3.0.CO;2-Q. Int J Cancer. 1996. PMID: 8824545

7

Increased immunogenicity of tumors bearing mutant p53 and P1A epitopes after transduction of B7-1 via recombinant adenovirus.

Lee CT, Ciernik IF, Wu S, Tang DC, Chen HL, Truelson JM, Carbone DP. Lee CT, et al. Among authors: carbone dp. Cancer Gene Ther. 1996 Jul-Aug;3(4):238-44. Cancer Gene Ther. 1996. PMID: 8853548

8

Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor.

Lee CT, Wu S, Ciernik IF, Chen H, Nadaf-Rahrov S, Gabrilovich D, Carbone DP. Lee CT, et al. Among authors: carbone dp. Hum Gene Ther. 1997 Jan 20;8(2):187-93. doi: 10.1089/hum.1997.8.2-187. Hum Gene Ther. 1997. PMID: 9017422

9

p53 as a target for anti-cancer immunotherapy.

Chen HL, Carbone DP. Chen HL, et al. Among authors: carbone dp. Mol Med Today. 1997 Apr;3(4):160-7. doi: 10.1016/S1357-4310(97)01003-4. Mol Med Today. 1997. PMID: 9134529 Review.

10

Increased dose-intensity in small-cell lung cancer: a failed strategy?

Johnson DH, Carbone DP. Johnson DH, et al. Among authors: carbone dp. J Clin Oncol. 1999 Aug;17(8):2297-9. doi: 10.1200/JCO.1999.17.8.2297. J Clin Oncol. 1999. PMID: 10561290 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters